These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 16312685

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of two antibiotic regimens for treatment of pelvic inflammatory disease.
    Soper DE, Despres B.
    Obstet Gynecol; 1988 Jul; 72(1):7-12. PubMed ID: 3132668
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial.
    Ness RB, Trautmann G, Richter HE, Randall H, Peipert JF, Nelson DB, Schubeck D, McNeeley SG, Trout W, Bass DC, Soper DE.
    Obstet Gynecol; 2005 Sep; 106(3):573-80. PubMed ID: 16135590
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the efficacy and safety of ceftizoxime with doxycycline versus conventional CDC therapies in the treatment of upper genital tract infection with or without a mass.
    Roy S, Wilkins J, March CM, Solera NC, Galvan NI, Ressler RL, Cendejas KA, Neal J, Azen CG, Essin DJ.
    Clin Ther; 1990 Sep; 12 Suppl C():53-73. PubMed ID: 2202512
    [Abstract] [Full Text] [Related]

  • 6. Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial.
    Savaris RF, Teixeira LM, Torres TG, Edelweiss MI, Moncada J, Schachter J.
    Obstet Gynecol; 2007 Jul; 110(1):53-60. PubMed ID: 17601896
    [Abstract] [Full Text] [Related]

  • 7. [Acute pelvic inflammatory disease: comparison of therapeutic protocols].
    Balbi G, Piscitelli V, Di Grazia F, Martini S, Balbi C, Cardone A.
    Minerva Ginecol; 1996 Jul; 48(1-2):19-23. PubMed ID: 8750486
    [Abstract] [Full Text] [Related]

  • 8. Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea.
    Del Rosso JQ, Schlessinger J, Werschler P.
    J Drugs Dermatol; 2008 Jun; 7(6):573-6. PubMed ID: 18561589
    [No Abstract] [Full Text] [Related]

  • 9. Side effects of doxycycline in adolescents treated for pelvic inflammatory disease.
    Risser W.
    J Pediatr Adolesc Gynecol; 2011 Jun; 24(3):e87. PubMed ID: 21601804
    [No Abstract] [Full Text] [Related]

  • 10. Adherence to oral therapies in pelvic inflammatory disease.
    Dunbar-Jacob J, Sereika SM, Foley SM, Bass DC, Ness RB.
    J Womens Health (Larchmt); 2004 Apr; 13(3):285-91. PubMed ID: 15130257
    [Abstract] [Full Text] [Related]

  • 11. Improvement in the clinical cure rate of outpatient management of pelvic inflammatory disease following a change in therapy.
    Piyadigamage A, Wilson J.
    Sex Transm Infect; 2005 Jun; 81(3):233-5. PubMed ID: 15923292
    [Abstract] [Full Text] [Related]

  • 12. Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea.
    Fowler JF.
    J Drugs Dermatol; 2007 Jun; 6(6):641-5. PubMed ID: 17668530
    [Abstract] [Full Text] [Related]

  • 13. Acute pelvic inflammatory disease. Etiologic and therapeutic considerations.
    Hemsell DL.
    J Reprod Med; 1988 Jan; 33(1 Suppl):119-23. PubMed ID: 3278107
    [Abstract] [Full Text] [Related]

  • 14. Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials.
    Haggerty CL, Ness RB.
    Clin Infect Dis; 2007 Apr 01; 44(7):953-60. PubMed ID: 17342647
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study.
    Judlin P, Liao Q, Liu Z, Reimnitz P, Hampel B, Arvis P.
    BJOG; 2010 Nov 01; 117(12):1475-84. PubMed ID: 20716255
    [Abstract] [Full Text] [Related]

  • 16. Upper and lower reproductive tract bacteria in 126 women with acute pelvic inflammatory disease. Microbial susceptibility and clinical response to four therapeutic regimens.
    Hemsell DL, Nobles BJ, Heard MC, Hemsell PG.
    J Reprod Med; 1988 Oct 01; 33(10):799-805. PubMed ID: 3193409
    [Abstract] [Full Text] [Related]

  • 17. [Drug treatment of acute adnexitis].
    Hoyme UB.
    Gynakologe; 1988 Mar 01; 21(1):26-30. PubMed ID: 3371755
    [No Abstract] [Full Text] [Related]

  • 18. Short-term prophylaxis in thoracic surgery: what regimen?
    Serrano S, Chessa L, Altomonte F, Camisa AL, Leoni C.
    Chemioterapia; 1987 Jun 01; 6(2 Suppl):579-80. PubMed ID: 3334630
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of different antibiotics in the treatment of pelvic inflammatory disease.
    Burchell HJ, Cronjé HS, de Wet JI.
    S Afr Med J; 1987 Aug 15; 72(4):248-9. PubMed ID: 3616808
    [Abstract] [Full Text] [Related]

  • 20. A comparative study of injection placentrex and conventional therapy in treatment of pelvic inflammatory disease.
    Garg R, Zahra F, Chandra JA, Vatsal P.
    J Indian Med Assoc; 2008 Jul 15; 106(7):463, 467. PubMed ID: 18975504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.